Skip to content
10-Q

Quarterly Report

HEALTH CATALYST, INC. HCAT

0001636422-26-000066

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 73.89M sh
Shares Diluted Q1 2026 · Mar 31, 2026 72.59M sh
Shares Diluted Q1 2026 · Mar 31, 2025 68.55M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $5M
Capex Q1 2026 · Mar 31, 2026 $338K
Capex Q1 2026 · Mar 31, 2025 $670K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $18.51M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $280K
Long Term Debt Q1 2026 · Mar 31, 2026 $151.74M
Long Term Debt Q1 2026 · Dec 31, 2025 $151.62M
Short Term Debt Q1 2026 · Mar 31, 2026 $1.63M
Short Term Debt Q1 2026 · Dec 31, 2025 $1.63M
Short Term Investments Q1 2026 · Mar 31, 2026 $48.96M
Short Term Investments Q1 2026 · Dec 31, 2025 $44.92M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $59.86M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $50.81M
Stockholders Equity Q1 2026 · Mar 31, 2026 $138.15M
Stockholders Equity Q1 2026 · Dec 31, 2025 $245.78M
Stockholders Equity Q1 2026 · Mar 31, 2025 $376.81M
Stockholders Equity Q1 2026 · Dec 31, 2024 $365.21M
Current Liabilities Q1 2026 · Mar 31, 2026 $107.61M
Current Liabilities Q1 2026 · Dec 31, 2025 $89.57M
Total Liabilities Q1 2026 · Mar 31, 2026 $274.06M
Total Liabilities Q1 2026 · Dec 31, 2025 $256.86M
Current Assets Q1 2026 · Mar 31, 2026 $182.31M
Current Assets Q1 2026 · Dec 31, 2025 $169.31M
Total Assets Q1 2026 · Mar 31, 2026 $412.2M
Total Assets Q1 2026 · Dec 31, 2025 $502.64M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.53
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.35
Eps Basic Q1 2026 · Mar 31, 2026 −$1.53
Eps Basic Q1 2026 · Mar 31, 2025 −$0.35
Sga Expense Q1 2026 · Mar 31, 2026 $13.96M
Sga Expense Q1 2026 · Mar 31, 2025 $14.16M
Rd Expense Q1 2026 · Mar 31, 2026 $9.78M
Rd Expense Q1 2026 · Mar 31, 2025 $15.19M
Net Income Q1 2026 · Mar 31, 2026 −$111.03M
Net Income Q1 2026 · Mar 31, 2025 −$23.74M
Operating Income Q1 2026 · Mar 31, 2026 −$106.48M
Operating Income Q1 2026 · Mar 31, 2025 −$20.17M
Revenue Q1 2026 · Mar 31, 2026 $70.76M
Revenue Q1 2026 · Mar 31, 2025 $79.41M